Paid Clinical Trials in Elmhurst, IL
As of August 2026, 31 paid clinical trials are recruiting in Elmhurst, Illinois. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Elmhurst offers studies at sites including Elmhurst Memorial Hospital for conditions such as Breast Cancer, Macular Edema Secondary to Inflammation, Metastatic Renal Cell Carcinoma, Ovarian Carcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Elmhurst
Trials by drug in Elmhurst
Filter results
31 clinical trials
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
E-Mindfulness Approaches for Living After Breast Cancer
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Improving Safety, Patient Experience and Equity Through Shared Decision-making Huddles in Labor
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Top Research Study Locations in Elmhurst
Researchers run research studies in Elmhurst, IL at 10 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Elmhurst Memorial Hospital | Breast Cancer, Metastatic Renal Cell Carcinoma, Ovarian Carcinoma | 18 |
| Retina Associates | DME, Diabetic Macular Edema, Diabetic Macular Edema (DME) | 3 |
| Retina Associates, LTD | Macular Edema Secondary to Inflammation | 2 |
| Retina Associates, Ltd. | Age - Related Macular Degeneration (AMD), Geographic Atrophy (GA), Neovascular Age-Related Macular Degeneration (nAMD) | 2 |
| Clinical Study Site | Metastatic Colorectal Cancer (CRC) | 1 |
| Elmhurst Hospital Nancy Knowles Cancer Center | Metastatic Non-small Cell Lung Cancer | 1 |
| Endeavor Health | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Non-Small Cell Lung Cancer | 1 |
| Endeavor Health Elmhurst Hospital | Perinatal Decision Making | 1 |
| Illinois Back and Neck Institute | Lumbar Spinal Stenosis | 1 |
| Nancy W. Knowles Cancer Center | Multiple Myeloma | 1 |
Active & Upcoming Studies in Elmhurst (2026)
Recruiting trials in Elmhurst grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (21 active studies)
- Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer · Phase 3 · Summit Therapeutics
- This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1. · Phase 3 · Pfizer
Eye & vision (6 active studies)
- A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration · Phase 3 · Amgen
- CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME · Phase 3 · EyePoint Pharmaceuticals, Inc.
Mental health & behavior (1 active study)
- E-Mindfulness Approaches for Living After Breast Cancer · Phase 3 · NRG Oncology
Common conditions studied in Elmhurst
- Breast Cancer (2 active studies)
- Macular Edema Secondary to Inflammation (2 active studies)
- Metastatic Renal Cell Carcinoma (2 active studies)
- Ovarian Carcinoma (2 active studies)
- Stage IV Renal Cell Cancer AJCC v8 (2 active studies)
- Age - Related Macular Degeneration (AMD) (1 active study)
Leading research sponsors in Elmhurst
- NRG Oncology
- National Cancer Institute (NCI)
- Kodiak Sciences Inc
- 4D Molecular Therapeutics
- AbbVie
Frequently asked questions
How many paid clinical trials are currently recruiting in Elmhurst?
There are approximately 31 recruiting clinical trials in Elmhurst, Illinois listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Elmhurst pay participants?
Most recruiting trials in Elmhurst compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Elmhurst?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Elmhurst?
The most common conditions under active study in Elmhurst include Breast Cancer (2), Macular Edema Secondary to Inflammation (2), Metastatic Renal Cell Carcinoma (2), Ovarian Carcinoma (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Elmhurst?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Elmhurst on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Elmhurst?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Elmhurst?
Recruiting research sites in Elmhurst include Elmhurst Memorial Hospital, Retina Associates, Retina Associates, LTD, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Elmhurst right now?
The largest active categories in Elmhurst are Cancer & tumors (21), Eye & vision (6), Mental health & behavior (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.